PDS Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEOFrank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees24
Employees24
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2005
Founded2005
Employees24
Employees24
PDSB Key Statistics
Market cap43.83M
Market cap43.83M
Price-Earnings ratio-1.02
Price-Earnings ratio-1.02
Dividend yield—
Dividend yield—
Average volume1.15M
Average volume1.15M
High today$0.9899
High today$0.9899
Low today$0.90
Low today$0.90
Open price$0.95
Open price$0.95
Volume678.16K
Volume678.16K
52 Week high$3.41
52 Week high$3.41
52 Week low$0.8505
52 Week low$0.8505
PDSB News
TipRanks 4d
PDS Biotechnology Seeks FDA Meeting for PDS0101 ApprovalElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 4d
PDS Biotechnology to seek expedited approval pathway for PDS0101PDS Biotechnology (PDSB) announced that after recent review of the final VERSATILE-002 data, the Company has requested a meeting with the Food and Drug Administ...
TipRanks 6d
PDS Biotechnology’s Phase 3 Study: A Promising Update for Cancer TreatmentPds Biotechnology ((PDSB)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off...
People also own
Based on the portfolios of people who own PDSB. This list is generated using Robinhood data, and it’s not a recommendation.